Tuning silica nanoparticles for cell specific biotargeting
One of the key aims in biomedical science is to develop applications that can target and deliver drug to specific cell populations. Porous, non-toxic silica based structures have potential as biocompatible vehicles for intracellular delivery of an active ingredient. However, any modification to the original particle structure, such as the addition of an imaging agent, surface coating or a targeting agent, changes both its size and surface charge. This leads to changes in the stability of the particulate system.
Using both particle sizing using dynamic light scattering (DLS) and zeta potential measurements, the Finnish research team showed both direct and indirect effects on the suspension stability of functionalised silica particles as a result of surface modification. These results were published in the Journal of Nanomaterials in 2008. The team then went on, publishing results in ACS Nano in 2009 that used similar techniques to develop a multifunctional nanodevice for cancer therapy that demonstrated remarkably good cell specificity.
The size, stability and cell specificity of functionalised nanoparticles for targeted drug delivery is crucially dependent on each surface modification as well as the overall surface charge. Besides the fact that surface charge along with particle size are directly decisive for a nanoparticles’ biodistribution, other highly critical factors, such as cytotoxicity and the efficiency of cellular uptake, are associated with nanoparticle size. While the technique of dynamic light scattering (DLS) is ideally suited for the determination of particle size, zeta potential measurements indicate the repulsive force that is present and can be used to predict the long-term stability of the product.
Most read news
Topics
Organizations
Other news from the department science
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
DynaPro Plate Reader III by Wyatt Technology
Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)
Efficiently characterize your sample quality and stability from lead discovery to quality control
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.